Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma

NCT00567567 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00567567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00567567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
November 5, 2007
Completion date
March 31, 2022
Enrollment
665 (actual)
Sites
190

Conditions

As the registry lists them; a condition with its own page is linked.

localized resectable neuroblastoma, localized unresectable neuroblastoma, recurrent neuroblastoma, regional neuroblastoma, stage 4 neuroblastoma, stage 4s neuroblastoma